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Background: The only hereditary neurologic disorder described so far in American Staffordshire
Terriers is adult-onset cerebellar degeneration secondary to ceroid lipofuscinosis. We have seen
several dogs with a newly recognized neurological disease characterized by locomotor weakness
with or without respiratory signs and juvenile onset consistent with degenerative polyneuropa-
thy of genetic origin.
Objectives: To characterize a novel polyneuropathy in juvenile American Staffordshire Terriers.
Animals: Fourteen American Staffordshire Terriers presented with clinical signs consistent with
juvenile-onset polyneuropathy at 5 veterinary hospitals between May 2005 and July 2017.
Methods: Case series. Dogs were included retrospectively after a diagnosis of degenerative
polyneuropathy had been confirmed by nerve biopsy. Clinical, pathological, electrophysiological,
histological data, and outcome were reviewed and a pedigree analysis performed.
Results: All dogs displayed clinical signs of neuromuscular disease with generalized motor and
sensory involvement, associated with focal signs of laryngeal paralysis (10/14 dogs) and megae-
sophagus (1/14 dogs). Histopathological findings were consistent with degenerative polyneuro-
pathy. Follow-up was available for 11 dogs, and 3 dogs were euthanized shortly after diagnosis.
In these 11 dogs, the disease was slowly progressive and the animals maintained good quality of
life with ability to walk. Pedigree analysis was mostly consistent with an autosomal recessive
mode of inheritance.
Conclusions and Clinical Importance: Juvenile polyneuropathy, associated with laryngeal paraly-
sis, is a newly described entity in American Staffordshire Terriers, and results from degenerative
neuropathy. When surgery for laryngeal paralysis is performed, lifespan may be similar to that of
normal dogs even though affected dogs have locomotor disturbance.
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1 | INTRODUCTION
Degenerative polyneuropathies (PNs) have been described in more
than 20 breeds of dogs, most of the disorders being hereditary, with a
demonstrated familial link among cases. An autosomal recessive
(AR) mode of transmission often is suspected.1 Juvenile hereditary
PNs associated with laryngeal paralysis (LP) have been identified in
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the Dalmatian, Leonberger, Pyrenean Mountain Dog, Greyhound,
Alaskan Malamute, Boxer, Black Russian Terrier, and Rottweiler, with
variable ages of onset, clinical signs, and prognosis.2–10So far, such a
disease has not been described in American Staffordshire Ter-
riers (ASTs).
Inherited PNs can either be syndromic, as part of a degenerative
process involving the central and peripheral nervous system, or non-
syndromic, with clinical signs only related to PN.1 In the Black Russian
Terrier, Rottweiler, and Boxer, the disease is syndromic with vacuola-
tion in the neuronal cell bodies, axons and adrenal cells, and ocular
abnormalities, similar to Warburg syndrome in humans.8,9,11 A causa-
tive mutation in the RAB3GAP1 gene has been identified in the Black
Russian Terrier and Rottweiler.9,11 In the other breeds, nonsyndromic
forms lead to a disease similar to Charcot-Marie-Tooth (CMT) disease
in humans, with axonal degeneration being a dominant finding.2–7,12,13
Mutations have been found for the Alaskan Malamute and Grey-
hound (NDRG1 gene), and for the Leonberger (ARHGEF10 and GJA9
genes), which allows for genetic screening.5,14,15
In most breeds, disease prognosis is reported to be poor, with
death or euthanasia occurring shortly after diagnosis.1,2,4,5,7 Some
Alaskan Malamutes and Leonbergers have been reported to have pro-
gressive disease with survival ranging from several months to several
years.7,12
To date, the only inherited degenerative disorder described in the
AST is ceroid lipofuscinosis. In this breed, an arylsulfatase G (ARSG)
mutation leads to a sulfatase deficiency and therefore to neuronal cer-
oid lipofuscinosis, eventually resulting in neuronal apoptosis and
adult-onset cerebellar ataxia.16,17 We have observed a progressive
neurological disorder with juvenile-onset locomotor and respiratory
signs and neurological examination findings consistent with PN in the
AST. The aims of our study were to establish the phenotype of this
newly described disorder, to determine its prognosis and to investi-
gate the possibility of a genetic origin.
2 | MATERIALS AND METHODS
2.1 | Case selection
Fourteen ASTs that showed clinical signs consistent with a PN with or
without respiratory signs including inspiratory stridor and dyspnea,
consistent with LP, of juvenile onset were presented between May
2005 and July 2017, and retrospectively included in the study. All
dogs were confirmed to have degenerative PN after histological eval-
uation of peripheral nerve biopsy samples.
2.2 | Clinical and pathological evaluation
Clinical records were analyzed and results of clinical and neurological
evaluations were reviewed. Results of additional diagnostic evalua-
tion, such as hematology, serum biochemistry profile, assessment of
thyroid function, cerebrospinal fluid analysis, infectious disease testing
and results of diagnostic imaging, including thoracic radiographs, mag-
netic resonance imaging (MRI) and laryngoscopy were reviewed when
available, as well as information regarding outcome after several
months to years.
2.3 | Electrodiagnostic testing
The results of an electrophysiological examination, when performed, were
reviewed. Any abnormal spontaneous activity, such as fibrillation potentials
and positive sharp waves, was reported. Compound muscle action poten-
tials (CMAP), motor nerve conduction velocities (MNCV), late latency
action potentials (F-waves), sensory nerve conduction velocities (SNCVs),
and results of repetitive nerve stimulation were analyzed. Electrophysiolog-
ical data were interpreted in comparison with published values.18
2.4 | Histopathology
The results of the histological examination of muscle biopsy samples were
reviewed. Biopsy samples were obtained by an open procedure, then
immediately frozen in isopentane, cooled in liquid nitrogen (−130C), and
stored at −80C until processed. Transverse cryosections (10 μm thick)
were stained by standard protocols, including hematoxylin-eosin (H&E),
modified Gomori trichrome (TG), ATPase pH 9.4, ATPase pH 4.65,
ATPase pH 4.35, and 2,4-dinitrophenylhydrazine stains. Depending on
the dog, at least 1 of the following muscles: tibialis cranialis (8 dogs),
biceps femoris (6 dogs), triceps brachii (6 dogs), and extensor carpi radialis
(5 dogs), was sampled. For each biopsy sample, the degree of myofiber
atrophy was evaluated and graded as mild (+), moderate (++), or marked
(+++), defined as follows: mild (rare angular myofibers); moderate (multifo-
cal diffuse angular myofibers); marked (myofibers reduced to pyknotic
nuclear clumps or fascicular atrophy). Fiber type grouping and intramus-
cular nerve branches also were evaluated.
Nerve biopsy samples were taken from all dogs. Peroneal nerve
biopsies were available for all dogs. Further biopsy sites were the
recurrent laryngeal nerve (dog 9) and the ulnar nerve (dogs 9 and 14).
All nerve biopsy samples, except those from dog 2, were routinely
fixed in 2.5% glutaraldehyde and contrasted with osmium tetroxide.
One sample was embedded in epoxy resin whereas another under-
went nerve fiber teasing, for longitudinal analysis.19 The embedded
tissues were sectioned at 0.5 μm, stained with azure II methylene
blue-safranin O and examined microscopically according to standard
algorithms.19 For dog 2, the nerve was routinely stained with H&E.
Based on the extent of nerve fiber lesions (including fiber loss, demye-
linative changes, node-paranode disruption and axonal degeneration)
and regenerative changes (including remyelination, axonal sprouts,
and regenerative clusters), the overall severity of nerve lesions was
graded semiquantitatively as mild (+), moderate (++), or marked (+++).
One dog (dog 9) was euthanized because of respiratory distress,
and the entire nervous system was obtained and analyzed post mortem.
2.5 | Pedigree analysis
All available pedigrees were compiled and the familial relationships
among the dogs were investigated. Information about the disease sta-
tus of the parents and littermates was reviewed when available.
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3 | RESULTS
A summary of the data obtained from individual dogs is available in
Supporting Information Table S1.
3.1 | Signalement, history, and clinical signs
Fourteen dogs were included in the study. Nine dogs were males and
5 were females. Median age at onset of clinical signs was 5 months
(range, 1-6 months). Information regarding age at onset of clinical
signs was not available for 2 dogs, which both were reported to have
a chronic history of juvenile-onset locomotor signs. Median age at
consultation was 15 months (range, 5-73 months).
All of the dogs had histories of chronic abnormal gait with or
without inspiratory dyspnea. Ten dogs had both respiratory and loco-
motor signs. For 5 dogs, inspiratory dyspnea was the first clinical sign
to be observed. These dogs subsequently developed locomotor signs,
with a delay of 1-6 months (median, 3 months) between the respira-
tory and locomotor signs. One dog also had regurgitation. One dog
(dog 1) was presented with a chronic history of locomotor signs and
acute respiratory signs with inspiratory dyspnea 4 days before presen-
tation. In the other 4 dogs, respiratory and locomotor signs appeared
at the same time. Four dogs had only locomotor signs. Clinical signs
were always slowly progressive.
Physical examination disclosed inspiratory dyspnea and stridor
consistent with LP in the 10 dogs with respiratory signs. All of the
dogs were presented with gait abnormalities, including ambulatory
flaccid tetraparesis and 4-limb ataxia (12 dogs) with the pelvic limbs
often more affected than the thoracic limbs (9/12 dogs), paraparesis
(2 dogs), high-stepping pelvic limb gait, compensating for cranial tibial
muscle atrophy by dropping of the hock, or pseudo-hypermetria of
the hock (8 dogs), ankylosis of the knee and tarsus (3 dogs), and palmi-
grade (4 dogs) and plantigrade (3 dogs) stance. Atrophy of the distal
musculature was reported in 8 dogs. Postural reactions were delayed
in all dogs, the pelvic limbs being more affected than the thoracic
limbs. Spinal reflexes were decreased or absent in all dogs. With-
drawal reflex in the pelvic limbs was the most consistently affected
spinal reflex (all dogs). Withdrawal reflex in the thoracic limbs was
decreased in 8 dogs. Nociception was decreased in 9 dogs when pres-
sure of a tissue forceps was applied to a digit as a noxious stimulus.
One dog (dog 2) had retinal dysplasia. See Supporting Information
videos S1 and S2.
3.2 | Clinicopathological findings
Results of routine biochemical analyses and CBC, available for 10 and
6 dogs, respectively, were within reference ranges, as was the albumin
to globulin ratio. Creatine kinase activities were mildly but increased
in 3 dogs (median, 515 UI/L; range, 457-878 UI/L; reference range,
47-370 UI/L) and within reference ranges in 4 dogs. Serum choles-
terol concentration (5 dogs), triglyceride concentrations (4 dogs), and
serum thyroxine and thyroid-stimulating hormone concentrations
(6 dogs) were within reference ranges. Results of acetylcholine recep-
tor antibody titer serology were within reference range in 1 dog. Cere-
brospinal fluid was obtained from 2 dogs by cisternal puncture, and
analysis was within reference ranges. Serological tests were per-
formed in 2 dogs for neosporosis and 3 dogs for toxoplasmosis, and
results were negative.
3.3 | Imaging
Magnetic resonance imaging of the brain and cervical spinal cord was
performed in 2 dogs and results were normal in 1 dog. In the other
dog, MRI disclosed a decreased cerebellar size associated with
increased size of the cerebellar sulci. Thoracic radiographs, performed
in 3 dogs, were normal in 2 dogs and showed megaesophagus in 1 dog
(dog 9) with regurgitation. Laryngoscopy was performed in 7 dogs with
respiratory signs and was consistent with bilateral LP. Endoscopy of
the esophagus was performed in dog 9 and was consistent with mega-
esophagus, with decreased esophageal motility reported.
3.4 | Electrodiagnostic testing
Electrodiagnostic tests were performed in 13 dogs and results were
consistent with generalized, predominantly axonal and demyelinating,
motor and sensory PN. Electromyography (EMG) identified spontane-
ous activity with fibrillation potentials and positive sharp waves in
most appendicular muscles in all dogs except 1 (dog 13). The intensity
of spontaneous activity was greater in the distal muscles in 4 dogs,
greater in the proximal muscles in 1 dog and equal in all muscles in the
other dogs. Laryngeal muscles were tested in 7 dogs, including 6 with
LP and 1 without LP, all of which showed abnormal spontaneous
activity.
Motor nerve conduction velocities and CMAP amplitudes were
recorded in at least 2 nerves in different limbs in the 13 dogs. The
results are presented in Table 1 and compared with published data.17
A summary of the data for individual dogs is available in Supporting
Information Table S2.
For some dogs, MNCV could not be determined because no
CMAP could be obtained despite maximal nerve stimulation (2 of
10 dogs for the peroneal nerve, 7 of 12 dogs for the tibial nerve, 2 of
7 dogs for the radial nerve, and 7 of 13 dogs for the ulnar nerve; over-
all, 43% of the conduction studies performed). Motor nerve conduc-
tion velocities and CMAP amplitudes were consistently decreased,
the CMAP amplitudes showing a greater decrease in proportion when
compared to the reference values than MNCVs. Typical features are
presented in Figure 1. F-wave latencies were obtained in 5 dogs and
were increased in 2 of them. Sensory nerve action potentials could
only be obtained for the radial nerves of 2 dogs (dogs 1 and 13), and
the SNCVs (33 m/s and 37.1 m/s) were markedly decreased in com-
parison with published data. Repetitive nerve stimulation was per-
formed in 4 dogs and gave normal results.
3.5 | Histopathology
The results of histopathological analysis of the muscle and nerve
biopsy samples are presented in Table 2.
Twenty-six muscle biopsies were performed in 11 dogs. Histological
analysis identified abnormalities consistent with denervation, including
variability in myofiber size with atrophic and angular fibers of both fiber
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types, variable degrees of fibrosis, and irregular distribution of oxidative
enzyme activities. Fiber type grouping occasionally was seen and type II
fiber predominance was frequent. No inflammation was detected. Dorsal
cricoarythenoideus muscle biopsy samples, obtained from 2 dogs with
LP, displayed the same features. When several muscle biopsy samples
were taken from the same limb (6 dogs), the distal muscles were more
affected (3 dogs), or equally affected (2 dogs) as compared to the proxi-
mal muscles. Intramuscular nerve branches displayed decreased myelin-
ated fiber density with features of axonal degeneration. Muscle
histological features are presented in Figure 2.
Nerve histology allowed diagnosis of PN in all cases. Myelinated
fiber loss was severe in 6/14, moderate in 6/14, and mild in 2/14. Resid-
ual nerve fibers showed mild (2/14), moderate (1/14), or severe changes
(11/14). Thus, 2 cases were consistent with intermediate neuropathy
(2/14) and 2 cases (2/14) were affected by a diffusely demyelinating
nerve disease. In the other 9/14 dogs, a compound nodo-paranodal neu-
ropathy predominated, with (4/9) or without (5/9) lymphohistiocytic
infiltrates confined to the nodal-paranodal area. Other demyelinating
features were identified. A mild demyelinating neuropathy was reported
for dog 2. Primary axonal features resembled active Wallerian degenera-
tion with some dystrophic axons. Rare fibers undergoing Wallerian
degeneration stages III-IV as well as axonal atrophy in fibers, featuring
extensive demyelinating changes, were considered to be secondary
axonal involvement. In 8/11 cases, myelin ballooning was identified and
4 of these dogs also had tomacula. A mild increase in endoneural lym-
phocytes and histiocytes was seen in all dogs with nodal infiltrates and in
3 dogs without nodal infiltrates. Onion bulbs were evident in 3 dogs.
Regenerative fiber clusters occurred in 1 dog only.
In 1 dog, complete neurodissection of the central nervous system
was normal. Nerve histological features are presented in Figures 3
and 4.
3.6 | Follow-up
Three dogs were lost to follow-up. Follow-up (up to 6 years after diag-
nosis) was available for 11 dogs. Three dogs were euthanized shortly
(1 day to 2 months) after diagnosis. Two of these dogs, including the
1 with megaesophagus, had locomotor signs and LP, and 1 dog (dog 1)
without LP was euthanized 4 days after diagnosis. Among the remain-
ing 8 dogs, 5 had LP. Three dogs with LP underwent surgery for
arythenoid cartilage lateralization. One dog (dog 7) is still alive and
ambulatory 2 years after surgery. One dog (dog 4) was euthanized
6 years after surgery for reasons unrelated to the disease. One dog
(dog 14) died for an unrelated reason (rodenticide toxicosis) 5 months
after diagnosis. Among the 2 remaining dogs that did not undergo sur-
gery, 1 dog (dog 13) was reported to have mild improvement with
decreased stridor after corticosteroid administration 4 months after
TABLE 1 Motor nerve conduction velocities and compound muscle action potential amplitudes for proximal and distal stimulations when
recorded for radial (n = 5), ulnar (n = 6), tibial (n = 5), and peroneal (n = 8) nerves, in comparison with published values17
Range Mean Reference
MNCV (m/s) Radial 16.9-37 24 72.1  1.9
Ulnar 17-37.5 25.1 58.9  1
Tibial 20.5-54.5 38 68.2  1.4
Peroneal 14-52.3 19.5 79.8 1.8
Amp (mV) Radial Proximal 3-11.9 4.5 23.4  1.5
Distal 1.1-13.1 6 21.6  1.6
Ulnar Proximal 0.4-13.3 2.1 22.9  1.6
Distal 0.9-16.1 1.7 25.8  1.8
Tibial Proximal 0.1-21.8 14.1 20.1  1.6
Distal 0.2-16.9 8.3 23.3  2.3
Peroneal Proximal 1-26.6 7.9 19.8  1.4
Distal 2-15.4 3.35 19.5  1.5
Amp, amplitude; MNCV, motor nerve conduction velocity.
FIGURE 1 Recordings of compound muscle action potentials with proximal (A2: hip) and distal (A1: fibula) stimulations of the peroneal nerve of
an affected dog (dog 7) with recording in the tibialis cranialis muscle. Note the marked decrease in compound muscle action potential (CMAP)
amplitudes (reference range: proximal: 19.8  1.8 mV, distal: 19.5  1.5 mV), the polyphasic aspect of the CMAP and the mild decrease in motor
nerve conduction velocity (reference range: 79.8  1.8 m/s), demonstrating predominantly axonal but also demyelinating involvements
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diagnosis and the other dog (dog 11) is stable 1 year after the diagno-
sis, according to its owners. The 3 other dogs with only locomotor
signs are still alive 6 months to 2 years after diagnosis. All of these
dogs are still ambulatory. According to their owners, the disease is
either stable or slowly progressive.
3.7 | Pedigree analysis
The 14 dogs came from 11 different litters and 3 dogs were siblings.
Six pedigrees (for 8 dogs) were reviewed and a 5-generation pedigree
analysis was performed. The family pedigree of the dogs is shown in
Figure 5. Genetic analysis determined that 6 dogs had a common
ancestor. The other 2 dogs were not related to this family. Many
inbreeding loops were identified and 1 dog was a backcross. Both
males and females were affected, and none of the parents was
reported to have had clinical signs. Data concerning disease status
could not be obtained for all the littermates. Nevertheless, the preva-
lence of the disease in 2 litters of the family pedigree with littermates
was at least 25%.
4 | DISCUSSION
We describe a novel motor and sensory, distal and mainly axonal,
degenerative nonsyndromic PN of juvenile onset in AST with fair
prognosis in comparison with data reported for other breeds.
The disease is very likely to be nonsyndromic in AST, whereas in
the Rottweiler, Black Russian Terrier, and Boxer, PN with LP is a syn-
dromic disease. In these breeds, affected dogs also exhibit ophthalmo-
logic abnormalities such as microphthalmia, cataracts, miotic pupils,
and persistent pupillary membranes.8–11,20 None of the dogs included
in our study exhibited microphthalmia, miotic pupils, or persistant
pupillary membranes although full ophthalmological examination was
available only for 3 dogs. Retinal dysplasia was identified in 1 dog.
This finding has not been reported in PN with ocular abnormalities
and neuronal vacuolation and is in itself thought to be an inherited
ocular disorder in ASTs.21 Brain MRI examinations are not reported in
syndromic polyneuropathy of Rottweiler, Black Russian Terrier, and
Boxer, except for 1 case, a Rottweiler, in which brain MRI was nor-
mal.22 This examination, available for 3 dogs from our cohort, dis-
closed central nervous system involvement in only 1 case. In this dog,
slight cerebellar atrophy was observed without clinical signs of cere-
bellar dysfunction. This anomaly is probably not associated with AST
PN and could represent an incidental finding. This cerebellar atrophy
remains of unknown origin because neither genetic testing for the
canine arylsulfatase G mutation nor histopathology of the cerebellum
was performed. The parents of this dog were not tested either.
Regarding the age of the dog, it is unlikely the result of ceroid lipofus-
cinosis, and congenital anomaly should be considered. Another argu-
ment against syndromic PN is that complete histology of the entire
nervous system in 1 affected dog failed to identify any lesions in
1 affected dog.
Nonsyndromic juvenile-onset hereditary motor and sensory poly-
neuropathies with LP have been reported in the Dalmatian, Leonber-
ger, Pyrenean Mountain Dog, Alaskan Malamute, and Greyhound with
various ages of onset and clinical signs (Table 3).1–10 The dogs in our
study shared many of the clinical features previously reported in these
other breeds. Age at onset of clinical signs in our cohort varied from
1 to 6 months for 12/14 affected dogs, allowing classification of the
disease as juvenile. A similar age was reported for Dalmatian, Pyre-
nean Mountain Dog, and Greyhound in which onset of clinical signs
TABLE 2 Degree of muscle and nerve alteration on biopsies
Dog Muscle biopsies Nerve biopsies
1 BF: +++, ERC: + Neuropathy type: NPN
Severity: +++
Fiber loss: +++
Inflammation: −
2 TC: + Severity: +
Fiber loss: +
Inflammation: −
3 TC: ++ Neuropathy type: NPN
Severity: +++
Fiber loss: ++
Inflammation: +
4 BF: ++, TB: +, ERC: + Neuropathy type: INP
Severity: +
Fiber loss: +
Inflammation: −
5 BF: +, TC: +++, TB: ++,
ERC: ++
Neuropathy type: NPN
Severity: +++
Fiber loss: +++
Inflammation: +/−
6 BF: ++, TC: ++, TB: ++ Neuropathy type: NPN
Severity: +++
Fiber loss: ++
Inflammation: +
7 BF: ++, TC: +++, TB: ++ Neuropathy type: INP
Severity: ++
Fiber loss: ++
Inflammation: +
8 Not performed Neuropathy type: NPN
Severity: +++
Fiber loss: +++
Inflammation: -
9 Not performed Neuropathy type: NPN
Severity: Fibular: ++, recurrent
laryngeal: +++, ulnar: +++
Fiber loss: ++ − +++
Inflammation: +
10 TC: +++, ERC: ++ Neuropathy type: NPN
Severity: +++
Fiber loss: +++
Inflammation: ++
11 Not performed Neuropathy type: NPN
Severity: +++
Fiber loss: ++
12 TB: +++ Neuropathy type: DNP
Severity: +++
Fiber loss: ++
Inflammation: +
13 ERC: +, BF: +, TC: + Neuropathy type: NPN
Severity: +++
Fiber loss: ++
Inflammation: +
14 TB: +++, TC: +++ Neuropathy type: NPN
Severity: Fibular: +++, ulnar: +++
Fiber loss: +++
Inflammation: +
BF, biceps femoris; ERC, extensor carpi radialis; TB, triceps brachii; TC,
tibialis cranialis; NPN, nodo-paranodopathy; INP, internodopathy; DNP,
demyelinating neuropathy.
+, mild; ++, moderate; +++, severe.
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occurs during the first year of life.1,2,4,5 In the Alaskan Malamute, clini-
cal signs occurred between 3 and 19 months of age.7,14 Finally, in the
Leonberger, clinical signs occurred between 1 and 3 years of age in
70% of the animals examined.12,23 In 2 dogs (dogs 1 and 4) from our
study, presentation was at 60 and 73 months of age, respectively, and
although no exact information was available about the age at onset of
clinical signs, the chronicity of the signs favored classification as juve-
nile onset. Dogs were presented with various degrees of the classical
FIGURE 2 Light microscopies of sections from fresh frozen muscle biopsies. A, Normal muscle, H&E stain. B, Mild myofiber atrophy. Note the
rare angular myofibers (asterisk). M. Extensor carpi radialis, dog 10, H&E stain. C, Moderate myofiber atrophy. Note the multifocal diffuse angular
myofibers (asterisk). M. Biceps femoris, dog 6, H&E stain. D, Marked myofiber atrophy. Note the myofibers reduced to pyknotic nuclear clumps.
M. Biceps femoris, dog 1, H&E stain. E, Marked myofiber atrophy. Note the fascicular atrophy (asterisk).M. tibialis cranialis, dog 7, H&E stain. F,
Atrophy of type 1 (light) and type 2 (dark) myofibers. M. tibialis cranialis, dog 2, ATP 9.4 stain
FIGURE 3 Light microscopy of a section from a fresh frozen muscle biopsy, nerve features. A, Transverse section of a normal intramuscular
nerve branch. M. Biceps femoris, TG stain. B, Transverse section of an intramuscular nerve branch showing myelinated fiber loss. M. Biceps
femoris, dog 6, TG stain. C, Transverse muscle section showing a longitudinal section of an abnormal intramuscular nerve branch with axonal
degeneration. M. Biceps femoris, H&E stain. D, Transverse muscle section showing a longitudinal section of an intramuscular nerve branch
showing axonal degeneration. M. tibialis cranialis, dog 10, TG stain
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motor and sensory signs of degenerative PN, reported in all affected
breeds.1,24 Locomotor signs included flaccid paresis, which involved
only the pelvic limbs or were more prominent in the pelvic limbs in
most of the dogs. High stepping pelvic limb gait was reported in half
of the dogs. The withdrawal reflex in the pelvic limbs always was
decreased or absent at least at the level of the hock. This finding is
consistent with distal PN and with an early clinical manifestation being
involvement of branches of the sciatic nerve. In the case of tibialis cra-
nialis muscle dysfunction (denervation), the hock joint cannot flex
properly and a typical compensatory gait, characterized by
hyperflexion of the proximal part of the limb, becomes apparent.1
Muscle atrophy mainly involved the distal appendicular muscles, as
reported in all of the other breeds. Sensory signs such as ataxia, pro-
prioceptive deficits and decreased nociception also were seen in
all dogs.
Focal signs of LP with or without regurgitation have been
reported in many PNs and were present in most of the dogs in our
cohort. Respiratory distress also has been reported to occur before
locomotor signs in the Dalmatian and Leonberger, as in numerous
dogs with acquired LP.2,12,25–30 Laryngeal paralysis was diagnosed
in most of the dogs and, in some, was the first clinical sign. Like the
sciatic nerve, the recurrent laryngeal nerve contains very long axons
and LP secondary to denervation can be the first clinical sign of
more diffuse PN.1 In the 5 dogs that initially were presented with
locomotor signs, subsequent acute respiratory signs explained by LP
were observed. Laryngoplasty led in many instances to clinical
improvement. Megaesophagus was diagnosed by endoscopy in the
sole dog that was presented with clinical signs of regurgitation. Two
other dogs underwent thoracic radiography but no abnormality was
identified. Clinical megaesphagus was a consistent finding in the
Pyrenean Mountain Dog and Alaskan Malamute, and frequently has
been reported in the Dalmatian. As in the Leonberger and Grey-
hound, clinical megaesophagus seems to be uncommon in affected
ASTs. However, in a study that investigated esophageal function in
dogs with idiopathic LP, the authors found that most of the dogs
(25/32) had abnormal esophageal motility, but less than one-third of
these dogs had clinical signs of dysphagia.29 For these reasons,
FIGURE 4 A-G, Peripheral nerve findings. Compared to advanced
stages of myelinated fiber loss (B,B0), mildly affected nerves appear
next to normal on histological slides (A,A0) and teased fiber
preparations (C), with physiological myelination and myelin
compaction, conformation of the nodes of Ranvier (C: NR) and
Schwann cells (C: SC). Moderately affected animals show fiber
atrophy with myelin sheath segmentation (D: Seg) with ovoid
formation, thickened paranodes (D: PN) and enlarged nodal gaps
because of paranodal retraction and tipped paranodes. In advanced
cases, myelin sheath shows ballooning (E: red frame) and tomaculous
paranodal thickening (E: black frame) next to demyelinated segments.
Remyelinated segments (F: RS) are occasionally seen whereas in other
cases progression results in osmiophobic ghost fibers (G: GF) and fiber
residues surrounded by collagen bundles (G: Col). Scale bars: A, B:
150 μm; A0 , B0 , C-G: 100 μm
FIGURE 5 Family pedigrees of the dogs. Squares indicate males and
circles indicate females. Filled symbols indicate affected dogs. Unfilled
symbols indicate unaffected animals. Gray symbols indicate animals
for which the clinical status is unknown
TABLE 3 Characteristics of the reported juvenile-onset nonsyndromic polyneuropathy and laryngeal paralysis in dogs
Breed Age of onset Clinical signs Prognosis Gene
Dalmatian 2-12 months L, LP, ME Guarded to poor Unknown
Leonberger <1-11 years L, LP Guarded to fair ARHGEF10 (20% of cases),
GJA9 (adult onset)
Pyrenean Mountain 2-5 months L, LP, ME Guarded to poor Unknown
Alaskan Malamute 3-19 months L, LP Fair NDRG1
Greyhound 3-9 months L, LP Poor NDRG1
L, locomotor; LP, laryngeal paralysis; ME, megaesophagus.
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esophageal hypomotility or subclinical megaesophagus might have
been underdiagnosed in our cohort of dogs. Postoperative aspira-
tion pneumonia after surgery for LP is more likely in dogs with
severe esophageal dysfunction diagnosed from an esophago-
gram.29,31 It may be advisable to obtain thoracic radiographs and, if
surgery is planned and megaesophagus is not present radiographi-
cally, to obtain esophagograms in affected dogs. No complication
was reported in the 3 dogs that underwent surgery, suggesting
either no or mild esophageal hypomotility.
Electrophysiological examinations were consistent with motor
and sensory, predominantly axonal, and demyelinating, distal
PN. Abnormal spontaneous electrical activity more often was found in
the distal muscles on EMG, which suggests distal PN. Similar findings
have been reported in the Pyrenean Mountain Dog, Greyhound, Dal-
matian, Alaskan Malamute, and Leonberger.2,4,5,7,12 Histological ana-
lyses of muscle biopsy samples were consistent with results obtained
by EMG, neurogenic atrophy often being more pronounced in the dis-
tal muscles. Distal involvement of the nerve was confirmed by the
small size of the intramuscular nerve branches. Variability of atrophy
was not associated with chronicity of clinical signs. Type II fiber pre-
dominance often is associated with neuropathic disorders and could
be explained by biopsies having been performed in areas of large type
II fiber grouping.32 Electroneurography consistently identified a
marked loss of CMAP amplitude and a mild to moderate decrease in
MNCV in all dogs. In contrast to humans, no MNCV cut-off value can
be used to separate demyelinating from axonal PNs in dogs, but these
findings suggest a predominantly axonal PN. In many dogs, the ampli-
tude of the motor response was too decreased to obtain latency mea-
surements.1 This finding also was reported in the Leonberger.12
Mixed electrodiagnostic features with more pronounced distal find-
ings, as observed in most of the dogs, are compatible with both inter-
mediate neuropathy and nodal-paranodal neuropathy as observed on
nerve histopathology.
This disorder differs from human axonal CMT types where degen-
erating axons intermingle with regenerative sprouts and clusters. Like-
wise, the observation of sparse onion bulbs centered on fibers lacking
full myelination is distinct from congenital dysmyelinating neuropathy
in people. The occurrence of tomacula in some cases raises the ques-
tion of myelin sheath instability phenotype hereditary neuropathy
with liability to pressure palsies. However, a minority of dogs showed
a clinically relevant amount of tomacula, and hereditary neuropathy
with predilection for pressure palsies typically is not accompanied by
myelin sheath ballooning and features of nodal-paranodal neuropathy.
On the contrary, the combination of myelin sheath changes in older
dogs might be seen in metabolic disorders such as Cushing's disease
and insulinoma. Moreover, an association with risk of immune-
mediated neuropathy requires consideration.
In the other breeds, PN and LP have been reported to be associ-
ated with poor prognosis resulting in death or euthanasia a few
months after diagnosis, often as a consequence of aspiration pneumo-
nia, despite palliative treatment.2,4,5,7 Nine of the 11 Alaskan Mala-
mutes included in a previous study were euthanized soon after
diagnosis, because of their poor condition, but 2 dogs were still alive
36 and 42 months, respectively, after diagnosis, and thus the disease
may be slowly progressive.7 In the Leonberger, prognosis is reported
to be fair, with gradual clinical worsening within months to a few
years. In another study, 9 of the 21 dogs received surgical correction
for LP, resulting in clinical improvement.12 In 2 dogs, locomotor weak-
ness progressed to quadriplegia. At the end of the study, 8 dogs were
alive and still ambulatory, and the other dogs were euthanized, died of
aspiration pneumonia or were lost to follow-up. Duration of follow-up
was not specified. The prognosis was reported to be worse for dogs in
which the onset of clinical signs occurred earlier and the course of the
disease was more severe and progressed more rapidly.12 The disease
prognosis in AST seems to be fair in comparison to other breeds, and
many dogs survive for a longer time that has been reported in other
breeds. The severity of the clinical signs in our dogs was variable. Two
dogs with both locomotor and respiratory signs were euthanized soon
after diagnosis because of their poor medical condition. One of these
dogs had megaesphagus and regurgitation. In the dogs with respira-
tory and locomotor signs, for which follow-up was available, LP was
responsible for acute worsening of clinical signs, but both dogs
improved after surgery. Regarding those dogs with locomotor signs
only, 1 was euthanized at the owner's request but was still ambulatory
before euthanasia, and 3 dogs were still alive, with a slowly progres-
sive disorder, 6 months to 2 years after diagnosis. For dogs presented
with locomotor signs only, the prognosis seems to be good and it
seems to be fair for dogs presented with LP, once surgery has been
performed. The rare occurrence of clinical megaesophagus, associated
with a higher risk for secondary aspiration pneumonia, might explain
the better prognosis in comparison to the Dalmatian and Pyrenean
Mountain Dog.
To some extent, the progression of PNLP in AST seems compara-
ble to the progression of CMT disease in humans, which typically
occurs during the first or second decade of life and is slowly progres-
sive with no alteration of life expectancy in most cases.33,34 The natu-
ral history of axonal degenerative PNs, or type 2 CMT, was studied
prospectively over 5 years.3 Very few patients were nonambulatory at
the beginning of the study. The disease typically was slowly progres-
sive, but none of the initially ambulatory patients lost their ability to
walk during the follow-up period.35 Some patients with severe disease
are unable to ambulate in infancy or early childhood.34 Vocal cord
dysfunction caused by vagus and laryngeal neuropathies has been
reported in association with several CMT types, and this dysfunction
is not related to the severity of neuromuscular weakness.34 Both
laryngeal and pharyngeal dysfunction can occur in hereditary and
acquired neuropathy with axonal involvement, and also in acquired,
immune-mediated nodal-paranodal neuropathy.19
The juvenile onset of clinical signs in our dogs is consistent with
an inherited disorder. Both males and females were affected, and
none of the parents was reported to have clinical signs. Some pedi-
grees are missing and data concerning disease status could not be
obtained for all of the littermates. Nevertheless, the prevalence of the
disease in the aforementioned litters was at least 25%. For all these
reasons, an AR mode of inheritance can be suspected. Additional data
are needed to confirm that the disease is inherited and to identify its
mode of inheritance.
To our knowledge, ours is the first description of juvenile PNLP in
ASTs. The disease results from degenerative neuropathy and very
likely is inherited. When surgery for LP is performed, the majority of
2010 VANDENBERGHE ET AL.
dogs can have a longer lifespan than reported for dogs affected by
other breed-related PNs, despite locomotor disturbance.
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